Back to search

Selegiline hydrochloride and cognition

Data up to Jan 2025

Published1991
Citations24
References23

Total Citations Per Year

Abstract

References (23)

Effect of Deprenyl on the Progression of Disability in Early Parkinson's Disease

1989 • 913 citations

Deprenyl is metabolized to methamphetamine and amphetamine in man.

1978 • 287 citations

AGEING, MONOAMINES, AND MONOAMINE-OXIDASE LEVELS

1972 • 263 citations

Increased activity of brain and platelet monoamine oxidase in dementia of Alzheimer type

1980 • 254 citations

BRADYPHRENIA IN PARKINSON'S DISEASE AND PSYCHOMOTOR RETARDATION IN DEPRESSIVE ILLNESS

1987 • 220 citations

The possible mechanisms of action of (-)deprenyl in Parkinson's disease

1978 • 207 citations

A Controlled Study of the Antidepressant Efficacy and Side Effects of ( — )-Deprenyl

1989 • 175 citations

Effects of a MAO-B Inhibitor in the Treatment of Alzheimer Disease

1991 • 145 citations

The effect of β-phenylethylamine on central and peripheral monoamine-containing neurons

1967 • 133 citations

Cognitive effects of l-deprenyl in Alzheimer's disease

1987 • 127 citations

Neuropsychological Effects of L-Deprenyl in Alzheimerʼs Type Dementia

1990 • 114 citations

L-Deprenil, A Selective Monoamine Oxidase Type B Inhibitor, in the Treatment of Depression: A Double Blind Evaluation

1983 • 94 citations

Is the failure of (-)deprenyl, a selective monoamine oxidase B inhibitor, to alleviate depression related to freedom from the cheese effect?

1981 • 90 citations

Deprenyl in Parkinson disease

1981 • 88 citations

L-deprenyl, a selective monoamine oxidase type-b inhibitor in endogenous depression

1980 • 86 citations

l-Deprenyl in Atypical Depressives

1984 • 85 citations

Tyramine pressor sensitivity changes during deprenyl treatment

1985 • 81 citations

Phenylethylamine: evidence for a direct, postsynaptic dopamine-receptor stimulating action

1977 • 75 citations

Platelet MAO activity in primary degenerative dementia

1984 • 52 citations

Monoamine Oxidase and Dementia: Treatment with an Inhibitor of MAO-B Activity

1990 • 29 citations

The effect of deprenyl (selegiline) on cognition and emotion in parkinsonian patients undergoing long-term levodopa treatment

1983 • 27 citations

New approaches in the use of selegiline for the treatment of Parkinson's disease

1989 • 16 citations

Genetic Markers in Epilepsy

1981 • 14 citations

Cited By (0)

Loading...